SkylineDx

SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in dermatology, hematology, and inflammatory diseases. SkylineDx uses its expertise to bridge the gap between academically discovered gene expression signatures and commercially available diagnostic products with high clinical utility, assisting healthcare professionals in accurately determining the type or status of disease or predicting a patient’s response to treatment. Based on test results, healthcare professionals can tailor the treatment approach to the individual patient. SkylineDx is headquartered in the Netherlands, complemented by a US base of operations and a CAP/CLIA certified laboratory in San Diego California, USA.